Investing in public graphene stocks - Page 33

Haydale has announced that it has been awarded funding of £138,549 (around USD$192,290) to develop hydrogen fuel cell tanks by the Advanced Propulsion Centre (APC).

To support the future of green automotive manufacturing and accelerate the UK's transition to net- zero emission vehicles, the Advanced Propulsion Centre (APC) has guided £9.4 million in public funding to 22 feasibility studies looking to scale up the industrialization of low-carbon emission vehicle technologies.

ZEN Graphene Solutions recently announced a non-brokered private placement, for gross proceeds of up to CAD$2,000,000 (around USD$1.59 million). Now, Zen has updated that due to "strong demand", it has increased the size of the Offering.

The gross proceeds will now be up to CDN$4,000,000 (over USD$3.16 million) - doubling the initial planned total.

Inbrain Neuroelectronics, spun-off from the Catalan Institute of Nanoscience and Nanotechnology (ICN2) and Icrea (and associated with the Graphene Flagship), recently announced closing a $16.85 million (€14.3 million) round led by Asabys and Alta. The company has also received financial backing from Cdti and two international investors.

NBRAIN Neuroelectronics was established in 2019 with the mission of developing brain-implants based on graphene technology for applications in patients with epilepsy, Parkinson’s, and other neuronal diseases. These smart devices, built around an innovative graphene electrode, will decode with high certainty neural signals from the brain and produce a therapeutic response adapted to the clinical condition of the specific patient.

Haydale has announced that it has been awarded a £1.1 million loan facility by Innovate UK Loans Limited, a wholly owned subsidiary of UK Research and Innovation.

Haydale, with the support of Innovate UK, is implementing its plan to expand its capacity to manufacture functionalized nanomaterials (including graphene) to meet growing demand. Haydale will be investing in a HT1400 plasma reactor and ancillary equipment to provide a facility to be able to increase production volume by at least eight-fold once fully optimized. The reactor will increase production at the Ammanford facility to an industrial level with capacity to functionalize over 30 TPA of graphene and other nanomaterials on a single shift pattern.

ZEN Graphene Solutions has announced a non-brokered private placement, for gross proceeds of up to CAD$2,000,000 (around USD$1.59 million).

The proceeds of this offering will be used for capital expenditures in the scale up of the production of ZEN's biocidal coating material, operating expenses at both Guelph locations, capital expenditures at the York Rd, Guelph manufacturing facility, graphene research and for general working capital.

Applied Graphene Materials (AGM) recently gave financial updates, as part of which the Company stated it is looking forward to stronger sales growth and has enough cash to fund operations well into 2023 after a £5.5 million fundraise in January.

AGM said it continues to develop its dispersed GNP technology platform and the potential to extend this to adjacencies applicable to the coatings sector. AGM added that significant progress has been made with coatings customers, and it is now starting to see repeat business with some long-range engagements.

In October 2020 we reported that Grafoid and Stria Lithium have announced a reverse takeover which will result in Grafoid becoming a wholly-owned subsidiary of Stria Lithium.

Grafoid now announced that the deal is terminated "Due to matters beyond the reasonable control of Stria and Grafoid".

G6 Materials (Formerly called Graphene 3D Lab) has made plans to raise $5 million CAD via a non-brokered offering. The company also announced plans to acquire GX Technologies in an all-share deal (worth around $7.5 million CAD).

GX Technologies is developing applications based on graphene oxide. GXT has a cooperative R&D agreement with the US Army Corps of Engineers to develop graphene oxide-based membranes for use in nanofiltration. The deal with GXT is expected to be closed before April 29, 2021.

Skeleton Technologies recently announced plans to develop new production technology and fully automate manufacturing in its Großröhrsdorf factory. The manufacturer of graphene-enhanced supercapacitors has unveiled plans to develop a first-of-its-kind production technology for the manufacturing of its products, following the official support announced by German authorities. These plans include a fully-automated ultracapacitor production line in its Großröhrsdorf factory. The economies of scale provided by this new technology, combined with the use of Skeleton’s patented curved graphene material, is expected to dramatically drive the production costs down.

We are continuously investing in R&D whether it is improving the performance of our products or the process in which we make those products. The next stage of our production will see an implementation of fully automated Industry 4.0 manufacturing techniques a first-of-its-kind in the ultracapacitor industry. Coupled with our curved graphene material, we are able to dramatically decrease the cost of ultracapacitors. The ultracapacitor industry is in the same situation as lithium-ion batteries were in 1999, but our advancements in core technology and production capabilities will be able to show a cost reduction faster than for any other energy storage technology. We have a clear road map to lower it by almost 90% after completion of our 5 years project, says Taavi Madiberk, CEO and co-founder of Skeleton Technologies, in a press release.

Skeleton Technologies, Estonia-based manufacturer of graphene-enhanced supercapacitors, and Marubeni Corporation, one of Japan’s largest conglomerates, have signed a strategic cooperation agreement to support commercial scale-up and customer acquisition for Skeleton’s supercapacitors in the Asian automotive sector, with a strong focus on electrified vehicles and hydrogen transportation.

As part of this agreement, Marubeni Corporation also made an equity investment on top of the €41.3 million Series D financing round announced by Skeleton in November 2020. The sum of Marubeni’s investment was not disclosed.